Subject
Obstetrics and Gynecology,Reproductive Medicine
Reference27 articles.
1. New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin;Jayne;Int J Womens Health,2017
2. Flibanserin therapy and CYP2C19 genotype;Dean,2019
3. A controversial drug for female hypoactive sexual desire disorder;Baid;Ind Psychiatr J,2018
4. U.S. Food and Drug Administration. Approval for Addyi (flibanserin) tablets Assessed on Feb, 2022 https://www.access data.fda.gov/drugsatfda_docs/label/ 2019/022526s009lbl.pdf#page=23
5. Flibanserin: first global approval;Deeks;Drugs,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献